Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heart Rate Reduction Via Oral Ivabradine During Exercise in Healthy Adults
NCT07717710Phase 1Recruiting
- Sponsor
- University of British Columbia
- Start
- Oct 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ivabradine in tachycardia, sponsored by University of British Columbia. Primary endpoint: Peak Heart Rate. Started Oct 2026; status: recruiting.
02
Drugs
ivabradine
03
Conditions
tachycardia
Beyond the preview
Go deeper on NCT07717710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717710.